Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,108 | 106 | 96.3% |
| Education | $81.95 | 2 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $746.73 | 44 | $0 (2024) |
| Lilly USA, LLC | $332.79 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $177.18 | 5 | $0 (2024) |
| Celgene Corporation | $164.43 | 3 | $0 (2018) |
| GENZYME CORPORATION | $143.79 | 6 | $0 (2024) |
| Amgen Inc. | $140.26 | 7 | $0 (2024) |
| Allergan, Inc. | $95.36 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $89.85 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $54.86 | 3 | $0 (2019) |
| UCB, Inc. | $47.50 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $491.47 | 20 | ABBVIE INC. ($161.68) |
| 2023 | $360.06 | 20 | ABBVIE INC. ($178.80) |
| 2022 | $265.57 | 16 | ABBVIE INC. ($119.31) |
| 2021 | $152.51 | 8 | AbbVie Inc. ($49.90) |
| 2020 | $57.31 | 3 | AbbVie Inc. ($37.10) |
| 2019 | $272.98 | 15 | Lilly USA, LLC ($99.45) |
| 2018 | $444.48 | 19 | Celgene Corporation ($164.43) |
| 2017 | $145.59 | 7 | AbbVie, Inc. ($35.09) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: FACIAL AESTHETICS | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $73.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 06/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Immunology | ||||||
| 05/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $8.78 | General |
| 04/23/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Immunology | ||||||
| 03/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: FACIAL AESTHETICS | ||||||
| 02/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT, DUPIXENT | Food and Beverage | In-kind items and services | $38.53 | General |
| Category: Immunology | ||||||
| 01/23/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Dermatology | ||||||
| 11/13/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Inflammation | ||||||
| 11/09/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: Dermatology | ||||||
| 11/06/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Immunology | ||||||
| 10/02/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 5,191 | 10,334 | $1.2M | $480,502 |
| 2022 | 32 | 5,247 | 10,038 | $1.2M | $500,763 |
| 2021 | 33 | 5,243 | 11,277 | $1.3M | $545,429 |
| 2020 | 37 | 5,021 | 9,949 | $1.2M | $475,256 |
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 176 | 213 | $241,016 | $106,099 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 904 | 1,076 | $159,031 | $64,074 | 40.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,047 | 1,363 | $168,557 | $56,915 | 33.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 446 | 528 | $90,221 | $39,509 | 43.8% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 80 | 107 | $74,311 | $37,005 | 49.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 681 | 780 | $72,561 | $29,191 | 40.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 846 | 5,067 | $57,481 | $26,247 | 45.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 94 | 99 | $50,381 | $21,410 | 42.5% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 91 | 92 | $48,646 | $15,585 | 32.0% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 27 | 33 | $20,640 | $10,113 | 49.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 62 | 71 | $20,154 | $9,346 | 46.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 103 | 160 | $13,501 | $6,713 | 49.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 73 | 79 | $14,874 | $6,415 | 43.1% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 28 | 28 | $14,506 | $5,595 | 38.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 47 | 48 | $19,597 | $5,229 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $13,522 | $4,652 | 34.4% |
| 12053 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm | Office | 2023 | 25 | 25 | $15,250 | $4,440 | 29.1% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 27 | 28 | $6,701 | $3,363 | 50.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 27 | 28 | $12,981 | $3,263 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 34 | $7,112 | $3,000 | 42.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 25 | $7,468 | $2,913 | 39.0% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 26 | 26 | $11,577 | $2,902 | 25.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 29 | 30 | $6,344 | $2,792 | 44.0% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 23 | 24 | $10,117 | $2,539 | 25.1% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 15 | 15 | $7,146 | $2,508 | 35.1% |
About Dr. Mark Gaughan, MD
Dr. Mark Gaughan, MD is a Dermatology healthcare provider based in Durango, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790792851.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Gaughan, MD has received a total of $2,190 in payments from pharmaceutical and medical device companies, with $491.47 received in 2024. These payments were reported across 108 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,108).
As a Medicare-enrolled provider, Gaughan has provided services to 20,702 Medicare beneficiaries, totaling 41,598 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Durango, CO
- Active Since 08/02/2006
- Last Updated 07/30/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1790792851
Products in Payments
- TALTZ (Drug) $332.79
- SKYRIZI (Biological) $309.41
- DUPIXENT (Biological) $269.21
- Otezla (Drug) $211.69
- Humira (Biological) $160.40
- RINVOQ (Biological) $134.00
- Enbrel (Biological) $73.71
- BOTOX COSMETIC (Biological) $61.81
- BOTOX (Biological) $53.87
- Bimzelx (Biological) $47.50
- OPZELURA (Drug) $46.58
- COSENTYX (Drug) $36.41
- BLU-U (Medical Supply) $35.23
- Tremfya (Drug) $32.15
- COSENTYX (Biological) $31.73
- DUPIXENT DUPILUMAB INJECTION (Biological) $30.71
- Ameluz (Drug) $23.57
- STELARA (Biological) $22.71
- Skyrizi (Biological) $21.94
- EPIDUO FORTE (Drug) $21.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Durango
Dr. Carmen Julian, D.o, D.O
Dermatology — Payments: $12,746
Dr. Geoffrey Farnsworth, M.d, M.D
Dermatology — Payments: $450.91
Lawrence Gaughan, Md, MD
Dermatology — Payments: $18.55
Susan Sanders, M.d, M.D
Dermatology — Payments: $17.18
Dr. Lindsey West, Md, MD
Dermatology